Generic Name: baloxavir marboxil
Brand Name: Xofluza
Manufacturer: Hoffmann-La Roche Limited
Therapeutic Area: Influenza
Indications: Treatment of uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours and who are otherwise healthy or at high risk of developing influenza complications.
Submission Type: Non-submission
Project Status: Not filed
Recommendation Type: CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer